On this page
Cell therapy for burns has a longer clinical history than almost anything else in this field: cultured skin grafting has been used in major burn units for decades. Stem cell therapy for burns means two quite different things, and only one of them is established practice in a hospital.
Two different things under one name
The first is cultured cell grafting: skin cells grown from a patient’s own small biopsy and applied as sheets or sprays to cover burns too large to graft conventionally. This is established practice in major burn centres and has been for decades.
The second is injection or application of mesenchymal cells to improve healing or scarring, which is investigational.
They are both accurately described as cell therapy for burns, and they are not the same offer. The first is performed in a hospital during acute management; the second is what appears in clinic advertising.
Knowing which is being proposed is the first question, and it decides everything else.
The randomised evidence
A randomised double-blind phase I trial tested fetal cell-based skin substitutes on donor sites in burn patients — A randomized, double-blind, phase I clinical trial of fetal cell-based skin substitutes on healing of donor sites in burn patients.
Donor sites are where skin is taken from for grafting, and they are a clean, comparable, measurable wound — which makes them a sensible place to test a healing treatment.
Autologous fat transfer has been studied in acute burn wound management — Effect of autologous fat transfer in acute burn wound management: A randomized controlled study — which is transferring fat tissue rather than isolated cells.
Both are randomised and both are early-phase. That is a better foundation than most pages on this site describe.
Eye burns are a genuine success story
Chemical burns to the eye surface can destroy the stem cell population at the edge of the cornea, leaving the eye unable to maintain a clear surface.
Transplanting limbal cells restores it, and the two main techniques have been compared directly — Simple limbal epithelial transplantation versus cultivated limbal epithelial transplantation in ocular burns.
This is genuine stem cell therapy with a defined cell population, a defined deficiency and a measurable outcome in vision.
It is also ophthalmic surgery performed by a corneal surgeon, and it has nothing to do with an intravenous infusion.
Scar treatment is a separate field
Burn scars are treated with a range of established approaches, and fractional laser is central to modern practice.
Trials in this area test additions to laser treatment — platelet-rich plasma and hyaluronic acid in burn scars — Evaluation of the efficacy, safety and satisfaction rates of platelet-rich plasma, non-cross-linked hyaluronic acid and the combination of platelet-rich plasma and non-cross-linked hyaluronic acid in patients with burn scars treated with fractional CO2 laser: A randomized controlled clinical trial.
Even pigment loss in burn scars has randomised work behind it — Evaluation of the efficacy, safety, and satisfaction rate of topical latanoprost in patients with hypopigmented burn scars treated with fractional CO2 laser: a double-blind randomized controlled clinical trial.
The pattern is consistent: cells and biologics are studied as additions to a procedure, not as replacements for burn surgery. Scar tissue and wound repair covers scarring more broadly.
Timing matters enormously
Acute burn care is time-critical and is provided by burn units. Fluid resuscitation, wound assessment, early excision and grafting determine survival and long-term function.
Nothing discussed here is an alternative to that, and nobody should be travelling for cell therapy during acute burn management.
The realistic window for what clinics offer is reconstruction and scar management months or years later, once healing is complete.
That is legitimate territory, and it is a plastic surgery and dermatology question with a cell therapy component under study, rather than the reverse.
What to expect
For established techniques in a burn unit: outcomes that are well documented and specific to the technique used.
For cell therapy added to scar management: possible improvement in scar quality, on early trial evidence, as an addition to laser or surgical treatment.
No published basis for expecting a mature scar to be removed, for contractures to release without surgery, or for pigment to return fully.
Contractures crossing joints restrict movement mechanically, and releasing them is a surgical procedure.
Risks
Infection in any wound or graft site, which is the principal hazard in burn care generally.
Donor site morbidity where tissue is harvested, in a patient whose available donor skin may already be limited.
Poor or unpredictable results in scar treatment, including worsening of pigmentation in some skin types.
Documented adverse events covers the wider safety picture.
Why cultured grafting mattered
Before it existed, a burn covering most of the body was frequently unsurvivable simply because there was not enough donor skin to cover it. Growing sheets from a postage-stamp biopsy changed that arithmetic.
The technique has real limitations — the sheets are fragile, they take weeks to grow, and long-term durability and scarring remain imperfect — and burn surgeons discuss those openly.
It remains one of the genuine successes of cell therapy, and it is worth knowing about because it demonstrates what the field looks like when it works: a defined cell population, a specific deficiency, a hospital setting and decades of outcome data.
Almost nothing sold as stem cell therapy for burns resembles that.
Questions worth asking
- Is this cultured grafting, fat transfer, or an infusion? They are entirely different.
- Who is performing it — a burn surgeon, a plastic surgeon, or a clinic doctor?
- How mature is my scar, and is this the right stage to intervene?
- Is this an addition to laser or surgical treatment, or a replacement for it?
The patient journey covers how assessment should work, and the evidence levels explain the grading.
Frequently asked questions
Is cell therapy for burns established?
Cultured skin grafting is established burn-unit practice and has been for decades. Injected cells for healing or scarring are investigational.
What is the randomised evidence?
A phase I randomised trial of fetal cell-based skin substitutes on donor sites, and a randomised study of autologous fat transfer in acute burns.
Can a mature scar be removed?
No published basis for that. Scar treatment aims at improving quality and appearance, and contractures crossing joints need surgical release.
What about burns to the eye?
Limbal cell transplantation for chemical eye burns is a genuine success story, and it is corneal surgery rather than an infusion.
Should I travel during acute burn treatment?
No. Acute burn care is time-critical and belongs in a burn unit. The realistic window for this is reconstruction months or years later.
Will an infusion help my burn scars?
The trials in this area test cells and biologics as additions to laser or surgical treatment, not as systemic infusions.
Requesting a medical evaluation
Nothing on this page establishes whether any treatment is appropriate for you. That needs your history, your imaging and your current medications read by a clinician. If you would like that review, send your records and we will tell you honestly whether there is anything worth discussing — including when the answer is no.
This page is general information, not medical advice, and does not create a doctor–patient relationship. Regenerative treatments discussed here are in most cases investigational. Discuss any treatment with a clinician who knows your history.